Skip to Main Content

Paper Details

Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.
PLoS One
1
2015
1, 162 genes, 552 promoters, Divergent Promoter, ERK, ErbB Receptor, FHL2, MAPK, MCF, MCF-7, MCF-7 human breast cancer cell line, cell, cell fates, epidermal growth factor, extracellular signal-regulated kinases, gene, generic promoters, half LIM domains 2, half LIM domains 2), heregulin, human, p53, promoter, promoters, stimulus-specific promoters
Author NameAffiliation
Daniel CarbajoAlbert Einstein College of Medicine
Masayoshi ItohRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Masayoshi Itoh
Masayoshi Itoh
Masayoshi ItohRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Masayoshi Itoh
Masayoshi Itoh
Hideya KawajiRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Hideya Kawaji
Hideya Kawaji
Hideya KawajiRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Hideya Kawaji
Hideya Kawaji
Timo LassmannRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Timo LassmannTelethon Kids Institute, The University of Western Australia
Timo Lassmann
Timo LassmannRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Timo Lassmann
Timo LassmannTelethon Kids Institute, The University of Western Australia
Erik ArnerRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Erik Arner
Erik ArnerKarolinska Institutet and Center for Metabolism and Endocrinology, Karolinska University Hospital
Alistair R R ForrestRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Alistair R R ForrestHarry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia
Alistair R R Forrest
Alistair R R ForrestRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Alistair R R Forrest
Alistair R R ForrestHarry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia
Piero CarninciRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Piero Carninci
Piero CarninciRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Piero Carninci
Yoshihide Hayashizaki
Yoshihide Hayashizaki
Yoshihide Hayashizaki
Yoshihide Hayashizaki
Carsten O DaubRIKEN Center for Life Science Technologies (Division of Genomic Technologies)
Carsten O Daub
Carsten O DaubKarolinska Institutet
Mariko Okada-HatakeyamaRIKEN Center for Integrative Medical Sciences
Jessica C MarAlbert Einstein College of Medicine
Jessica C MarAlbert Einstein College of Medicine
  • 1 - 42

Datasets

Release 1.2